### Company Update - Sustainability Report 2023-24 NATCO Pharma has released its Sustainability Report for 2023-24, reaffirming its commitment to sustainable practices across its operations.

The company is focusing on reducing its carbon footprint, with 15% of its energy sourced from renewables, targeting 35% by 2035 and aiming for carbon neutrality by 2050. The report highlights significant achievements, including the recycling of over 90% of waste and the use of zero liquid discharge at its major plants.

Key initiatives include a robust community engagement program with NATCO Trust, which has enhanced healthcare access through mobile health clinics and cancer care facilities, benefiting thousands.

The company's workforce has seen improvements, with a gender diversity rate of 10.9% and comprehensive employee welfare programs.

These efforts align with the UN Sustainable Development Goals, emphasizing NATCO’s role as a responsible corporate citizen and its dedication to creating a positive societal impact, positioning the company for both long-term sustainability and growth.

Investors are encouraged to monitor these developments closely, as they may indicate future profitability and market expansion opportunities.